GASTROESOPHAGEAL ADENOCARCINOMA
Clinical trials for GASTROESOPHAGEAL ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new GASTROESOPHAGEAL ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for GASTROESOPHAGEAL ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Radioactive drug trial seeks to target tough cancers
Disease control TerminatedThis early-stage study tested a new radioactive cancer treatment called [177Lu]Lu-FF58 in patients with advanced pancreatic, stomach, or brain cancers. The main goal was to find a safe dose and see how the body handles the drug. Researchers also used a special imaging scan to see…
Matched conditions: GASTROESOPHAGEAL ADENOCARCINOMA
Phase: PHASE1 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
Early cancer imaging study halted after limited testing
Diagnosis TerminatedThis was an early, first-in-human study to test a new radioactive imaging agent called [68Ga]-FF58. The goal was to see if it could safely and effectively highlight specific aggressive cancers (like glioblastoma and pancreatic cancer) during PET scans. The study was terminated ea…
Matched conditions: GASTROESOPHAGEAL ADENOCARCINOMA
Phase: EARLY_PHASE1 • Sponsor: Novartis Pharmaceuticals • Aim: Diagnosis
Last updated Mar 30, 2026 14:35 UTC